Macroleuco

Macroleuco Mechanism of Action

filgrastim

Manufacturer:

Dong-A

Distributor:

Metro Drug

Marketer:

Macropharma Corp
Full Prescribing Info
Action
Filgrastim (Macroleuco) is a recombinant human granulocyte colony stimulating factor (G-CSF, Filgrastim), which promotes the proliferation and differentiation of neutrophil precursors, the secretion of mature neutrophils from the bone marrow, and enhances the function of the mature neutrophils. Filgrastim (Macroleuco) was developed by Dong-A Pharmaceutical Co., Ltd. and is manufactured based on genetic engineering. Filgrastim (Macroleuco) has been verified for its safety and effect on neutropenia through clinical Trials.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in